InsiderTrades

Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/

Accepted 2022-10-17 00:00:00 ET · period of report 2022-10-13 · accession 0001209191-22-053832 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-10-17 2022-10-13 HRTX Peraza Lisa VP, CAO F - Tax $3.76 -861 20.6K -4% -$3,237
DM 2022-10-17 2022-10-13 HRTX Peraza Lisa VP, CAO M - OptEx — +2,485 21.4K +13% —
DM 2022-10-17 2022-10-13 HRTX Peraza Lisa VP, CAO M - OptEx $0.00 -2,485 15.7K -14% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-10-13 F D 861 $3.76 20,589 D — — (F2) Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions.
2 Common Common Stock 2022-10-13 M A 553 — 19,518 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
3 Common Common Stock 2022-10-13 M A 1,932 — 21,450 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
4 Derivative Restricted Stock Units 2022-10-13 M D 553 $0.00 4,416 D — · — to — 553 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020).
5 Derivative Restricted Stock Units 2022-10-13 M D 1,932 $0.00 15,694 D — · — to — 1,932 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021).